GLG LLC’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-16,588
Closed -$1.33M 593
2016
Q4
$1.33M Buy
16,588
+1,055
+7% +$83.7K 0.09% 232
2016
Q3
$1.24M Sell
15,533
-818
-5% -$66K 0.09% 245
2016
Q2
$1.28M Buy
+16,351
New +$1.17M 0.1% 221
2016
Q1
Sell
-19,625
Closed -$1.21M 589
2015
Q4
$1.21M Sell
19,625
-17,003
-46% -$1.07M 0.07% 268
2015
Q3
$2.31M Sell
36,628
-2,806
-7% -$200K 0.06% 277
2015
Q2
$2.88M Sell
39,434
-44,166
-53% -$3.19M 0.06% 293
2015
Q1
$5.47M Buy
83,600
+2,626
+3% +$175K 0.16% 170
2014
Q4
$5.27M Hold
80,974
0.16% 170
2014
Q3
$4.87M Hold
80,974
0.13% 215
2014
Q2
$5.61M Hold
80,974
0.17% 182
2014
Q1
$5.29M Buy
+80,974
New +$5.27M 0.18% 162

Other funds holding STJ

GLG LLC's STJ Position: Q1 2017 in Review

GLG LLC sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 16,588 shares — an estimated $1.33M sold.

GLG LLC first reported a position in STJ in Q1 2014 and held it in 11 quarters. The position peaked at $5.61M in Q2 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • GLG LLC reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • GLG LLC sold 16,588 St Jude Medical shares in Q1 2017, an estimated $1.33M.
  • GLG LLC first reported a position in St Jude Medical in Q1 2014 and held it in 11 quarters.
  • GLG LLC's St Jude Medical position peaked at $5.61M in Q2 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on GLG LLC's 13F filing for Q1 2017, filed 15 May 2017.